Tag: ichor

1
Mar

Ichor lands $1.35 million, attracts international investors

FOR IMMEDIATE RELEASE LaFayette, New York, March 2nd, 2016 Ichor Therapeutics, a local biotechnology company focusing on therapeutic interventions for age-related disease, receives $1.35 million in new funding — including $1 million from European investors — and begins a 4-fold expansion of research capabilities in LaFayette, NY to engage in FDA compliant pre-clinical research. Ichor was founded in 2013 by

Read more

7
Jul

Ichor awarded $80,000 grant for oncology research

LaFayette, NY (PRWEB) July 07, 2015 Ichor Therapeutics, Inc., a pre-clinical biotechnology company that develops technologies to target age-related pathology, announced today that it has received $79,775 in new grant funding from Methuselah Foundation, a 501(c)3 non-profit that funds regenerative medicine R&D. This news comes in response to pilot studies completed at Ichor during winter 2014-2015 where c60oo administration doubled

Read more